Genprex (GNPX) EPS (Basic) (2016 - 2025)
Genprex (GNPX) has 10 years of EPS (Basic) data on record, last reported at -$5.0 in Q3 2025.
- For Q3 2025, EPS (Basic) rose 98.52% year-over-year to -$5.0; the TTM value through Sep 2025 reached $334.15, up 195.82%, while the annual FY2024 figure was -$5.34, 76.33% up from the prior year.
- EPS (Basic) reached -$5.0 in Q3 2025 per GNPX's latest filing, down from -$0.17 in the prior quarter.
- Across five years, EPS (Basic) topped out at $339.58 in Q4 2024 and bottomed at -$338.06 in Q3 2024.
- Average EPS (Basic) over 5 years is -$2.5, with a median of -$0.17 recorded in 2025.
- Peak YoY movement for EPS (Basic): tumbled 13785.71% in 2022, then skyrocketed 9059.89% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.14 in 2021, then crashed by 13785.71% to -$19.44 in 2022, then soared by 80.5% to -$3.79 in 2023, then surged by 9059.89% to $339.58 in 2024, then plummeted by 101.47% to -$5.0 in 2025.
- Per Business Quant database, its latest 3 readings for EPS (Basic) were -$5.0 in Q3 2025, -$0.17 in Q2 2025, and -$0.26 in Q1 2025.